BRTX Stock UPDATES Biorestorative Therapies Inc (BRTX) 0.3300

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biorestorative Therapies Inc (BRTX) 0.3300 $BRTX

BioRestorative Therapies Engages Consulting Firm to Develop Strategic Partnerships in Japan and China
Business Wire - Mon Aug 18, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced the engagement of Tokyo-based Solution Partners Ltd. to develop strategic alliances in Japan and China for the Company's technologies. The agreement includes introductions to potential strategic partners and other alliance candidates, with the goal of expansion and development of the Company's ThermoStem(R) program, the Company's stem cell delivery device used in connection with the Company's brtx-DISC(TM) program and the Company's brtx-C Cosmetic program.

BioRestorative Therapies Issues Letter to Stockholders
Business Wire - Mon Jul 14, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, has issued a letter to stockholders, the text of which is below.

BioRestorative Therapies Appoints Joseph B. Swiader to its Board of Directors
Business Wire - Wed Jul 02, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of Joseph B. Swiader, age 54, to its Board of Directors. Mr. Swiader will chair the Nominating Committee and serve on the Compensation Committee of the Board.

BioRestorative Therapies Appoints The Honorable Paul Jude Tonna to its Board of Directors
Business Wire - Mon Jun 30, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of The Honorable Paul Jude Tonna to its Board of Directors. Mr. Tonna will serve on the Audit, Compensation and Nominating committees of the Board.

BioRestorative Therapies Signs Research and Development Agreement with Rohto Pharmaceutical
Business Wire - Tue Mar 25, 8:42AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement ("Agreement" with Rohto Pharmaceutical Company, Ltd. ("Rohto" . Under the Agreement, BRT has been engaged to provide stem cell research and development services.

BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
Business Wire - Mon Mar 03, 7:30AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a consulting agreement with Gregory Lutz, M.D. pursuant to which Dr. Lutz will serve as Chief Medical Advisor for Spine Medicine.

HMG Strategy Presents The 2014 CIO Summit of America - A Gathering of Global Executives in New York City
PR Newswire - Tue Jan 14, 12:54PM CST
HMG Strategy, the leading producer of CIO Executive Leadership Summits in North America, in partnership with the NY Metro Chapter of the Society for Information Management, will host the renowned CIO Summit of America on January 28, 2014 at The Harvard Club of New York City.

BioRestorative Therapies' Brown Fat Stem Cells Research Published in February Issue of Stem Cells Journal
Business Wire - Tue Jan 14, 10:51AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that a preclinical study that is part of its ThermoStem(R) program has been published in the February issue of the peer-reviewed journal, Stem Cells. A photograph of the Company's brown fat stem cell scaffold appears prominently on the cover. As previously announced, the newly identified human adult brown fat stem cells discussed in the study have the potential to lead to the development of a cell-based method for the treatment of type 2 diabetes and obesity.

OTC Daily Alert Stock Watch - BioRestorative Therapies, Inc. (OTCQB: BRTX)
WorldStockWire - Thu Aug 15, 8:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

BioRestorative Therapies Receives Approval to Conduct Retrospective Safety Study on its Bulging/Herniated Disc Procedure
PR Newswire - Tue Aug 06, 6:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has received approval from the Western Institutional Review Board ("the Board" to complete a retrospective safety study on selected subjects previously treated by the Company's brtxDISC(TM) bulging and herniated disc procedure. The study is titled "Re-consenting and Follow-Up of Adults from a Retrospective Study Using Autologous Transplantation of Marrow Derived Mesenchymal Stem Cells to Degenerated Intervertebral Disc."

BioRestorative Therapies Provides Company Updates with Shareholder Letter
PR Newswire - Thu Aug 01, 7:51AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, today announced the issuance of a shareholder letter by Chief Executive Officer, Mark Weinreb, providing an update to shareholders on the Company's progress.

BioRestorative Therapies CEO Mark Weinreb Interviewed by The Life Sciences Report
Marketwire - Thu Jul 25, 1:01PM CDT
"Millions of people suffer back pain caused by herniated and bulging disc disease. When conventional medical therapies fail, they often resort to surgery for relief, a costly and time-consuming solution for both patients and the medical system. In this interview with The Life Sciences Report, Mark Weinreb, president, CEO and chairman of BioRestorative Therapies Inc. (OTCQB: BRTX), describes how his company's cell therapy process could keep disc disease treatment out of the operating theater.

BioRestorative Therapies Expands its ThermoStem® Program to 150 Stem Cell Lines
PR Newswire - Mon Jun 24, 7:19AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, announced that it has expanded its ThermoStem® Program by collecting 150 samples of human brown adipose tissue (BAT). For the past year, through strategic collaboration and internal BRT efforts, the Company has grown a large library of human brown fat stem cells. The ThermoStem® Program, which is in the pre-clinical stage, focuses on the development of therapies using adult derived stem cells from brown adipose tissue to treat metabolic and obesity related disorders (particularly focusing on Type 2 Diabetes). The compilation of a large number and variety of brown fat derived stem cells allows BRT to study and identify potential cell lines to be used in developing therapies.

BioRestorative Therapies CEO Mark Weinreb Interviewed on "Next Big Thing" with Financial Personality and Founder Tobin Smith
PR Newswire - Mon Jun 17, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX) - Financial personality and Founder of NBT Equities Research, Tobin Smith, recently interviewed BioRestorative Therapies, Inc. (the "Company" CEO, Mark Weinreb, on the firm's hybrid business model and what the firm is currently doing that will help change the biotechnology landscape. BioRestorative is a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications.

BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products
PR Newswire - Wed May 29, 6:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has developed a human cellular-derived extract that, per initial in vitro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin production (proteins that are essential for combating the aging of skin). BRT plans to conduct additional in vitro studies to better understand the extract's mechanism of action and human cellular activity.

BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference
PR Newswire - Tue May 21, 6:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announced that Mark Weinreb, its President and CEO, will be presenting at the Marcum MicroCap Conference.

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC(TM) Stem Cell Therapy Device
PR Newswire - Mon May 20, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity" . Dexterity is a product design and bioengineering firm that will provide services to further the development and production of BRT's proprietary therapeutic delivery device for its intervertebral disc stem cell therapy program, "brtxDISC(TM)," (Disc Implanted Stem Cells).

BioRestorative Therapies Invited to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria
PR Newswire - Tue Apr 16, 9:25AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell based cellular therapies for various personal medical applications, announced today that it has been invited to present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria. The conference will take place April 18th-20th, 2013 at the Austria Center Vienna and will highlight early interventions for diabetes, dysglycemia, and surgery in the treatment of obesity and diabetes, where world leaders and specialists will discuss pioneering research in these areas.

BioRestorative Therapies Announces One-for-Fifty Reverse Stock Split
PR Newswire - Fri Apr 12, 3:00PM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on stem cell based cellular therapies for various personal medical applications, announced today that it will implement a one-for-fifty reverse stock split effective at the opening of business on April 15, 2013. Post-split the shares outstanding will go to 16,412,820 from 820,641,011. Additionally, in connection with the reverse stock split, the Company will also be reducing the number of shares of common stock authorized to be issued by the Company from 1,500,000,000 to 100,000,000 shares. For the 20-day period beginning April 15, 2013, the Company's stock will trade under the symbol "BRTXD" to designate that it is trading on a post-reverse split basis. Following that period, the common shares will resume trading under the symbol "BRTX".




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 255

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 211

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 102

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 199

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 99

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 374

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Crédit Agricole Assurances Reports Remarkable Growth in 2024

Updated Category News Views 81

Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...

Continue Reading
Enerpac Tool Group's Earnings Preview and Stock Insights

Updated Category News Views 72

Enerpac Tool Group's Upcoming Earnings Announcement Enerpac Tool Group (NYSE: EPAC) is set to release its quarterly earnings report shortly. This announcement is pivotal for both current investors and those considering an investment in the company. With analysts predicting an earnings per share (EPS) of $0.53, excitement is building around whether Enerpac will meet or...

Continue Reading
Unlocking Sales Potential: The Power of Unified Measurement

Updated Category News Views 163

Unlocking Sales Potential: The Power of Unified Measurement Marketing teams are faced with the challenge of demonstrating their impact amidst shifting sales channels. With the rise of platforms like Amazon, TikTok Shop, and other marketplaces, traditional measurement tools have fallen short, often focusing solely on .com sales. This shortfall can lead to up to 42% of...

Continue Reading
Rigel Pharmaceuticals Prepares for 2024 Financial Results Call

Updated Category News Views 81

Rigel Pharmaceuticals to Announce Fourth Quarter Results Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has made an important announcement detailing its plans to share its financial performance for the fourth quarter and the full year of 2024. This financial disclosure is scheduled to occur after the market closes on a day soon approaching in March. Details on the Conference...

Continue Reading
DENSO Partners for Michigan Workforce Development Initiatives

Updated Category News Views 213

DENSO Collaborates to Enhance Michigan's Workforce DENSO, a prominent mobility supplier, is making significant strides in workforce development by partnering with local businesses and organizations in Michigan. This collaboration has successfully secured over $550,000 in workforce training grants aimed at supporting leadership and skilled trades upskilling in the region....

Continue Reading